Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 18, 2018Journal of DiabetesOpen Access

International Diabetes Federation 2017

View Full Paper
Ask AI
Bookmark
Share

Authors

ACAnn M. CarracherThe Ohio State University Wexner Medical CenterPMPayal H. MaratheColumbia UniversityKCKelly L. CloseClose Concerns (United States)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Carracher et al. (2018) studied this question.

synapsesocial.com/papers/69d97d015e5bcb4e3b836cd4https://doi.org/10.1111/1753-0407.12644
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics2017 · 241 citations
  2. 2Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes2016 · 6,919 citations
  3. 3Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes2017 · 7,912 citations
  4. 4Towards an improved global understanding of treatment and outcomes in people with type 2 diabetes: Rationale and methods of the DISCOVER observational study program2017 · 56 citations